Advances in HFpEF Management (AHM)(CKM Navigation) : A Textbook of Cardiology

個数:

Advances in HFpEF Management (AHM)(CKM Navigation) : A Textbook of Cardiology

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 1078 p.
  • 言語 ENG
  • 商品コード 9789366167473

Full Description

HFpEF, or Heart Failure with preserved ejection fraction, is a type of heart failure where the heart's main pumping chamber (the left ventricle) becomes too stiff to fill properly with blood, even though it can still contract normally. This leads to symptoms like breathlessness, fatigue, and swelling due to blood and fluid backing up in the lungs and body. HFpEF is often associated with other conditions such as high blood pressure, diabetes, obesity, and heart disease, and treatment focuses on managing these underlying factors and relieving symptoms.

Based on the experience of more than 300 contributors, this book is a comprehensive guide to the diagnosis and management of HFpEF, explaining advances in clinical approach, imaging including echocardiography, and multimodality imaging; and drug, mechanical and surgical interventions.

Comprising 21 sections and169 chapters, as many as 28 chapters in this book deal with echocardiography and HFpEF. Assessment of HFpEF using echocardiographic techniques such as three-dimensional echocardiography and more recent advances such as speckle tracking of echocardiography for assessment of left ventricular, left atrial, right ventricular, and right atrial strain, are covered in depth.

Discussion on echocardiographic ventricular and atrial remodeling reversal with various therapeutic agents, including sodium-glucose cotransporter-2 (SGLT2) inhibitors, angiotensin receptor-neprilysin inhibitor (ARNI), and bisoprolol, is included.

Exercise-induced left atrial hypertension in HFpEF and the effect of various therapeutic agents on left atrial stiffness index, left atrial function, and other left ventricular diastolic parameters are also examined.

Contents

SECTION 1: HFpEF: CLINICAL SPECTRUM

SECTION 2: HFpEF AND DIAGNOSTIC BIOMARKERS

SECTION 3: HFpEF, ECHO AND IMAGING

SECTION 4: HFpEF AND CORONARY ARTERY DISEASE

SECTION 5: HFpEF AND ARRHYTHMIA

SECTION 6: HFpEF AND HYPERTENSION

SECTION 7: HFpEF AND PEDIATRICS

SECTION 8: HFpEF AND RENAL DISEASE

SECTION 10: HFpEF: CARDIO-OBSTETRICIAN AND GYNECOLOGY

SECTION 11: HFpEF: CARDIO-OPHTHALMOLOGY

SECTION 12: HFpEF AND CARDIODERMATOLOGY

SECTION 13: HFpEF, CARDIO-ENT AND CARDIOPULMONARY DISEASE

SECTION 14: HFpEF, CARDIODIABETES AND METABOLIC DISEASE

SECTION 15: HFpEF AND CARDIOLIPIDOLOGY

SECTION 16: HFpEF AND CARDIONUTRITION

SECTION 17: HFpEF AND CARDIO-ONCOLOGY

SECTION 18: HFpEF AND ECMO

SECTION 19: HFpEF AND THERAPEUTICS HFpEF and ARNI

SECTION 20: HFpEF AND REHABILITATION

SECTION 21: HFpEF AND FUTURE DIRECTION

最近チェックした商品